Altamira Therapeutics (formerly known as Auris Medical) is a biopharmaceutical company that provides therapeutics for medical needs in neurotology and central nervous system disorders. It develops intranasal betahistine for the treatment of vertigo and for the prevention of antipsychotic-induced weight gain and somnolence.